Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGoldPlat Regulatory News (GDP)

Share Price Information for GoldPlat (GDP)

Share Price is delayed by 15 minutes
Get Live Data
15.75    0.125 (0.80%)
Bid:
15.50
Ask:
16.00
Spread: 0.50 (3.226%)
Market Cap: £26.90m
GDP Live PriceLast checked at - London Stock Exchange

Intraday GoldPlat Share Chart

Update on consideration receivable for Kilimapesa

19 Jul 2021 07:00

RNS Number : 6348F
Goldplat plc
19 July 2021
 

Goldplat plc / Ticker: GDP / Index: AIM / Sector: Mining & Exploration

 

 

19 July 2021

 

Goldplat plc

('Goldplat', the 'Group' or 'the Company')

 

Update on the Consideration Receivable for the Sale of Kilimapesa Gold (Pty) Limited ('Kilimapesa')

 

 

Goldplat plc, the AIM quoted gold producer, with international gold recovery operations located in South Africa and Ghana, is pleased to provide an update on the consideration receivable on the sale of Kilimapesa to Mayflower Gold Investments Limited ('Mayflower Gold').

 

As announced on 26 April 2021, the initial consideration receivable by Gold Mineral Resources Ltd, Goldplat's subsidiary, is in the form of a secured debenture of USD1,500,000, to be satisfied by cash and/or the issue of shares to that value in Papillon Holdings plc ('Papillon'), payable on Papillon's re-admission to trading on the London Stock Exchange ('LSE') following completion of its proposed reverse takeover of Mayflower Gold, with 30% (USD450,000) of the initial consideration payable in cash. In the event that Papillon was not re-admitted to trading on the LSE by 16 July 2021, the full initial consideration of USD1,500,000 would become payable in cash and attract interest of 4% with effect from 1 January 2021.

 

Goldplat has provided Mayflower Gold and Papillon an extension to 23 August 2021 to complete the re-admission to trading on the LSE.

 

For further information visit www.goldplat.com, follow on Twitter @GoldPlatPlc or contact:

 

Werner Klingenberg

 

Goldplat plc

(CEO)

 

Tel: +27 (0) 82 051 1071

Colin Aaronson / George Grainger

 

Grant Thornton UK LLP

(Nominated Adviser)

Tel: +44 (0) 20 7383 5100

 

Jessica Cave / Jessica Cave/ Lydia Zychowska

 

WH Ireland Limited

(Broker)

 

Tel: +44 (0) 207 220 1666

 

Tim Thompson / Mark Edwards / Fergus Mellon

Flagstaff Strategic and Investor Communications

Tel: +44 (0) 207 129 1474

goldplat@flagstaffcomms.com

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU No. 596/2014) which is part of UK law by virtue of the European Union (withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUKOVRABUBARR
Date   Source Headline
29th May 20267:00 amRNSTotal Voting Rights
21st May 20267:00 amRNSDividend Declaration - Further Information
20th May 20267:00 amRNSQ3 Operating Results Update & Dividend Declaration
11th May 20261:48 pmRNSExercise of Options and PDMR Dealings
9th Apr 20269:56 amRNSUpdate on Tailings Storage Facility
18th Mar 20267:02 amRNSNotice of Investor Presentation
18th Mar 20267:00 amRNSInterim results for the 6-months ended 31 Dec 2025
17th Mar 20268:30 amRNSUpdate on release of interim accounts
17th Mar 20268:30 amRNSUpdate on release of interim accounts
20th Feb 202610:17 amRNSDirectorate update
10th Feb 20267:00 amRNSQ2 Operating Update for period ended 31 Dec 2025
5th Feb 20267:12 amRNSDirectorate change
2nd Feb 20267:00 amRNSTrading Update
20th Jan 202612:33 pmRNSResult of Reconvened AGM
6th Jan 20267:00 amRNSNotice of Reconvened AGM
29th Dec 202512:54 pmRNSResults of AGM and Adjournment of Meeting
29th Dec 202512:54 pmRNSResults of AGM and Adjournment of Meeting
15th Dec 20257:00 amRNSAudited Results for the year ended 30 June 2025
3rd Dec 20257:00 amRNSNotice of AGM & Board Change
14th Nov 20257:00 amRNSQ1 Operating Results and Dividend
29th Sep 20257:00 amRNSChange of Registered Office
4th Aug 20257:00 amRNSQ4 Operating Results, Trading Update and Dividend
1st Jul 20257:00 amRNSDirectors' Restricted Shares Cash Settlement
27th May 20257:00 amRNSQ3 Operating Results - period ended 31 March 2025
2nd May 20252:13 pmRNSTotal Voting Rights
22nd Apr 20252:48 pmRNSDirector's Dealing
15th Apr 20259:36 amRNSExercise of Options, Director's Dealings & TVR
10th Apr 20259:51 amRNSExercise of Options, Director's Dealings & TVR
24th Mar 20257:01 amRNSNotice of Investor Presentation
24th Mar 20257:00 amRNSInterim results for the 6-months ended 31 Dec 2024
12th Feb 202512:58 pmRNSCorrection: Q2 Operating Results
12th Feb 20257:00 amRNSQ2 Operating Results for period ended 31 Dec 2024
23rd Jan 202512:37 pmRNSResult of Reconvened AGM
9th Jan 20257:00 amRNSNotice of Reconvened Annual General Meeting
3rd Jan 20257:00 amRNSBoard Changes
30th Dec 202412:41 pmRNSResults of AGM and Adjournment of Meeting
20th Dec 202412:52 pmRNSAudited Results for the year ended 30 June 2024
5th Dec 20249:03 amRNS2024 Annual Results Update
5th Dec 20247:00 amRNSNotice of AGM
12th Nov 20247:00 amRNSQ1 Operating Results for period ended 30 Sept 2024
27th Sep 202411:59 amRNSDirectorate Change
27th Aug 20247:01 amRNSNotification of Investor Presentation
27th Aug 20247:00 amRNS4th Quarter Operating Results Update
16th Aug 20244:20 pmRNSKenya Tax Liability
15th Jul 20247:01 amRNSChange of Broker
2nd Jul 20247:00 amRNSRestricted Share Awards to Directors
17th Jun 202411:22 amRNSInvesting further in Local Beneficiation in Ghana
28th May 20248:24 amRNSGrant of Options and Restricted Share Awards
13th May 20247:00 amRNS3rd Quarter Operating Results update
19th Apr 20247:00 amRNSArrival of Generators

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.